文献速递糖尿病

基于糖化血红蛋白在两个社区队列中预测2型糖尿病

Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts.
PubMed 文献 · Diabetes Care · 2017-10-26

研究纳入弗雷明汉心脏研究和社区动脉粥样硬化风险研究中无糖尿病的白人和黑人中年参与者,评估糖化血红蛋白与偶发2型糖尿病的关联。 demographics调整后,糖化血红蛋白每升高1个百分点,2型糖尿病 odds 增加约4倍,合并OR为4.50;进一步调整空腹实验室检查和临床数据后,20年合并OR为2.68,8年内为5.79,8年后为2.23。结论认为糖化血红蛋白可在不同常见场景下预测2型糖尿病,有助于识别短期和长期风险升高个体。

要点

  • demographics调整后,糖化血红蛋白每升高1个百分点,2型糖尿病风险合并OR为4.50(95%CI 3.35, 6.03)。
  • 进一步调整空腹实验室检查和临床数据后,20年合并OR为2.68(95%CI 2.15, 3.34)。
  • 糖化血红蛋白与2型糖尿病关联在8年内(OR 5.79)和8年后(OR 2.23)均存在。

核心结论

  • 糖化血红蛋白可在不同常见临床信息场景下预测2型糖尿病,有助于识别短期和长期2型糖尿病风险升高的个体。

研究设计与样本

  • 前瞻性队列研究,纳入弗雷明汉心脏研究和社区动脉粥样硬化风险研究中无糖尿病的白人(N=11,244)和黑人(N=2,294)中年参与者。
  • 采用随机效应Meta分析合并队列和种族分析结果。
  • 2型糖尿病定义为使用药物或空腹血糖≥126 mg/dL。

主要发现

  • 中位随访20年间,3,315人发生2型糖尿病。
  • demographics调整后,糖化血红蛋白每升高1个百分点,黑人2型糖尿病OR为4.00(95%CI 3.14, 5.10),白人OR为4.73(95%CI 3.10, 7.21),合并OR为4.50(95%CI 3.35, 6.03)。
  • 进一步调整空腹实验室检查和临床数据后,20年合并OR为2.68(95%CI 2.15, 3.34),8年内合并OR为5.79(95%CI 2.51, 13.36),8年后合并OR为2.23(95%CI 1.94, 2.57)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hemoglobin A1c (HbA1c) can be used to assess type 2 diabetes (T2D) risk. We asked whether HbA1c was associated with T2D risk in four scenarios of clinical information availability: 1) HbA1c alone, 2) fasting laboratory tests, 3) clinic data, and 4) fasting laboratory tests and clinic data. RESEARCH DESIGN AND METHODS: We studied a prospective cohort of white (N = 11,244) and black (N = 2,294) middle-aged participants without diabetes in the Framingham Heart Study and Atherosclerosis Risk in Communities study. Association of HbA1c with incident T2D (defined by medication use or fasting glucose [FG] ≥126 mg/dL) was evaluated in regression models adjusted for 1) age and sex (demographics); 2) demographics, FG, HDL, and triglycerides; 3) demographics, BMI, blood pressure, and T2D family history; or 4) all preceding covariates. We combined results from cohort and race analyses by random-effects meta-analyses. Subsidiary analyses tested the association of HbA1c with developing T2D within 8 years or only after 8 years. RESULTS: Over 20 years, 3,315 individuals developed T2D. With adjustment for demographics, the odds of T2D increased fourfold for each percentage-unit increase in HbA1c. The odds ratio (OR) was 4.00 (95% CI 3.14, 5.10) for blacks and 4.73 (3.10, 7.21) for whites, resulting in a combined OR of 4.50 (3.35, 6.03). After adjustment for fasting laboratory tests and clinic data, the combined OR was 2.68 (2.15, 3.34) over 20 years, 5.79 (2.51, 13.36) within 8 years, and 2.23 (1.94, 2.57) after 8 years. CONCLUSIONS: HbA1c predicts T2D in different common scenarios and is useful for identifying individuals with elevated T2D risk in both the short- and long-term.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Leong A, Daya N, Porneala B, et al. Prediction of Type 2 Diabetes by Hemoglobin A1c in Two Community-Based Cohorts. Diabetes Care. 2017. PMID: 29074816. doi:10.2337/dc17-0607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。